Eden Research plc (LON:EDEN – Get Free Report)’s stock price traded up 2.8% on Tuesday following insider buying activity. The company traded as high as GBX 4.18 ($0.05) and last traded at GBX 3.70 ($0.05). 12,234,783 shares changed hands during trading, an increase of 664% from the average session volume of 1,602,016 shares. The stock had previously closed at GBX 3.60 ($0.04).
Specifically, insider Alexander John Abrey acquired 540,540 shares of Eden Research stock in a transaction that occurred on Tuesday, January 28th. The shares were purchased at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($26,902.58).
Eden Research Price Performance
The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.25. The company has a market capitalization of £19.73 million, a P/E ratio of -200.00 and a beta of 0.92. The business has a 50 day simple moving average of GBX 3.88 and a 200-day simple moving average of GBX 4.02.
About Eden Research
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
Featured Articles
- Five stocks we like better than Eden Research
- How to Read Stock Charts for Beginners
- What Does the Future Hold for Eli Lilly?
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
- Canadian Penny Stocks: Can They Make You Rich?
- 3 Consumer Stocks Call Option Traders Are Betting Big On
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.
